Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of the proposed Innovative Medicines Fund on personalised cancer treatments.
The Cancer Drugs Fund (CDF) has provided access to over 64,000 National Health Service patients to the most promising cancer medicines. The Innovative Medicines Fund (IMF) will build on and extend the successful CDF. NHS England and NHS Improvement and the National Institute for Health and Care Excellence expect to carry out an engagement exercise on detailed proposals for the IMF later this year.